HealthCor Catalio Acquisition Corp.

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: HC Sponsor
IPO Size: $150M
Underwriters: Jefferies
Focus: Healthcare, Life Sciences
SEC Filings: 1833769
Public Embarc Page: https://embarc.com/capital/spac/1833769/HCAQ/healthcor-catalio-acquisition
IPO Ticker: HCAQ

SPAC Leadership

Information on the SPAC leadership.

Chief Executive OfficerChristopher Gaulin
Chief Financial OfficerChristine Clarke, CPA
PresidentGeorge Petrocheilos
ChairmanJoseph Healey
DirectorAvi Horev
DirectorTaylor Harris
DirectorKenan Turnacioglu
DirectorMichael Weinstein
DirectorChristopher Wolfgang
Dr. Kenan Turnacioglu
Dr. Christopher Wolfgang

Target Information

Information on the SPAC target for merger.

Company: Hyperfine and Liminal Sciences
Presentation: Investor Presentation (SEC) on 2021-07-08
New Ticker: HYPR
Description: Hyperfine and Liminal are "two companies with the potential to drive a transformative shift in MRI and brain sensing technology and capabilities."